Internal Auditing in Research: The QA Process Research Education Series February 14, 2011 Sarah Dutkevitch, RN, OCN, Clinical Research Nurse Specialist.

Slides:



Advertisements
Similar presentations
1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team.
Advertisements

Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
CROMS NIDCR Clinical Monitoring
Tips to a Successful Monitoring Visit
Chicken Soup for the Busy Coordinator
USC Clinical Trials Office (CTO) Answers to CTOs who, what, when, and how questions Soheil Jadali Director, Clinical Trial Office.
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
RESEARCH COMPLIANCE Agenda 1. No Destruction of local research documents after scanning 2. Training for shipping biological samples/specimens 3. Regulatory.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
© Clinical Research Practice Clinical Research Organization and Management 1.
1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.
ProTECT III Regulatory & Project Management. Project Spoke Table This is where information about your Spokes is maintained This is where information about.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
YALE MASTER SLIDE HERE Clinical Research Management – Is not just a handshake deal? Jamie Caldwell, MBA Director Office of Research Services for the Health.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
November 10, Office of Research Administration: Clinical Research Contracting Presented to: Research Administration Professionals Group Patricia.
Brookhaven Science Associates U.S. Department of Energy 1 Brookhaven National Laboratory Protocol Compliance Monitoring Darcy Mallon May 7, 2009.
Unlocking the Mystery of General Information Reporting Research Compliance Administration Training Presentation Wednesday, June 6, 2007 Presenter:Heather.
Coordinator University Clinical Research Pharmacy Investigational Drug Service (IDS) Marjorie Shaw Phillips, MS, RPh, FASHP Clinical Research Pharmacist.
Yesterday, today, and tomorrow
Research and Development Protocol Submission and Continuing Review Processes Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas.
Revised Audit Manual – Fall Meeting 2009 September 30, 2009 REVISED AUDIT MANUAL Chris Steward, ACRIN Quality Control Auditor.
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
Pre-Award Issues Related to Human Research and Animal Use March 15, 2013.
Monitoring, Audits, and Inspection Oh my! Rachel Sheppard Regulatory Director, OCRSS.
New IRB Guideline Changes and Converting to eIRB - Suggestions for Maintaining Compliance. Ramesh Ghodgaonkar, BPHARM, MSITS, MSB, MBA Betsy Johnson, BA.
Common Audit Findings UTHSC Institutional Review Board (IRB)
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
Deciphering the Continuing Review Form Research Compliance Administration Training Presentation Wednesday, August 15, 2007 Presenter:Heather Kemp, MBA.
Patient Safety Friendly Hospital Intiative Purpose Implementation of a set of patient safety standards in hospitals Implementation of a set of patient.
Research Auditing Presented by: Darlene Krueger, MBA RN CCRA Chief, GCP Auditing & Training VA Cooperative Studies Program Albuquerque, NM.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
The QA/QI Process Human Research Subjects Protection Human Investigation Committee Tracy Rightmer, JD, CIP Compliance Manager.
H I P A A T R A I N I N G Self Directed Module 7 Research Disclosures For Data Custodians START Click to begin…
Privacy and Confidentiality. Definitions n Privacy - having control over the extent, timing, and circumstances of sharing oneself (physically, behaviorally,
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
AUDIT REQUIREMENTS, FINDINGS & BASICS RESEARCH COMPLIANCE.
Human Subjects Research Office of Responsible Research Practices Human Subjects Research Vanessa Hill, MSHS, CCRC Senior Quality Improvement Specialist.
Module C FDA Regulations Regulatory Documents Patricia E. Koziol 1Module C Final Version 10-apr-2010.
1 Auditing and Monitoring Gerald Beccia/RCO VA CT Healthcare System.
Paul Kelly Facility Research Compliance Officer for the Ralph H. Johnson VA Medical Center.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Office of Human Research Protection Georgia Health Sciences University.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
Sponsor Visits and Monitoring
ACRIN CV Committee ACRIN PDRC ACRIN PA 4008 Protocol and Regulatory Requirements Patricia Atkinson, Quality Control Monitor.
IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
Responsibilities of Sponsor, Investigator and Monitor
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Good Clinical Practice (GCP) and Monitoring Practices
The Role and Responsibilities of the Clinical Research Coordinator
Stephanie Oppenheimer, MS SUCCESS Center Erica Ellington, CRA, CHRC
Responsibilities of Sponsor, Investigator and Monitor
MAINTAINING THE INVESTIGATOR’S SITE FILE
IRB reporting updates.
Jamie Reddish, MPH Research Compliance Administrator
Reportable Events & Other IRB Updates February 2017
MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS
Elements of an Organized Regulatory Binder
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
CONDUCTING THE TRIAL AT
MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS
Protocol Approval Criteria
Epic Tools for Clinical Research
Good clinical practice
Presentation transcript:

Internal Auditing in Research: The QA Process Research Education Series February 14, 2011 Sarah Dutkevitch, RN, OCN, Clinical Research Nurse Specialist Heather Kemp, MBA, CCRP, Clinical Research Coordinator Department of Surgery, General Surgery Section

Agenda / Overview Assessing Risk in Auditing The SOP: Answering the Who, What, Where, When, Why, and How of Internal Auditing The Coordinator’s Perspective: Before, During, and After an Internal Audit

The Research Context Operational Oversight Finance Non- Therapeutic Operations Biospecimen Repositories Educational Research Imaging Research Research Databases Regulatory Therapeutic Operations Investigational Drug, Devices, and Procedures Nursing IUH North Hospital IUH University Hospital IUH West Hospital VA Medical Center Wishard Hospital Data Management

The Research Context Budgeting, Grants and Contracts, Account Management 1 Staff Member with Responsibilities in this Area 0.5 FTE Finance Subject Consenting, Specimen Collection and Processing, Hospital Staff Training, Data Collection and Management, Data Analysis, Manuscript Publication 6 Staff Members with Responsibilities in this Area 2.25 FTE Non-Therapeutic Operations Protocol Development, Regulatory Approvals (IRB, VA R&D, etc.), Regulatory Document Collection and Maintenance, Internal Auditing 2 Staff Members with Responsibilities in this Area 1.25 FTE Regulatory Subject Screening/Consenting/Enrollment/Management, Hospital Staff Training, Data Collection and Management, Data Analysis, Manuscript Publication 7 Staff Members with Responsibilities in this Area 5.0 FTE Therapeutic Operations

Answer the questions in Section I (page 1) of your handout to assess the context of your research group.

Why is it Audited? Compliance Process Improvement Education

Who is Audited? All research which: – Is not exempt from IRB review; – Is not being conducted under a waiver of informed consent; – Has subjects enrolled on the study; and – Has not been reviewed by the Clinical Trials Monitoring Committee in the past 12 months.

What is Audited? Informed Consent Documents and Informed Consent Process Documentation HIPAA Authorizations Subject Eligibility Protocol Compliance (Deviations and Violations) Subject Safety Compliance with the DSMP

Sponsored Trials: Exceptions to the Rule Informed Consent Documents and Informed Consent Process Documentation HIPAA Authorizations Subject Eligibility Protocol Compliance (Deviations and Violations) Subject Safety Compliance with the DSMP

Other Resources 1.Toward, J. (2010, November). Contrasting Health Canada and internal academic audit mechanisms and outcomes. SoCRA Source Journal, 66, Austin, DM. (2010, November). Investigational product accountability to ensure audit readiness. SoCRA Source Journal, 66, Korieth, K. (2011, February). The high cost and questionable impact of 100% SDV: Sponsors, CROs reluctant to alter standard practice. The CenterWatch Monthly, 18(2), pp.1,

Answer the questions in Section II (page 2) of your handout to assess the risks inherent in your research group.

Where and When is it Audited? Audits are Conducted in the Office/Clinic/Lab Where Study Charts are Stored Audits Fall in the Middle of the Continuing Review Cycle (±2 Months)

Where and When is it Audited? Audits are Conducted in the Office/Clinic/Lab Where Study Charts are Stored Audits Fall in the Middle of the Continuing Review Cycle (±2 Months) The Auditor Provides Written Notification to the PI and Lead Study Coordinator Approximately Two Weeks in Advance

The Notification RE:Internal Audit of Study No. [IRB No.] Dear Dr. [Name]: This is to remind you that the above-referenced study is scheduled to be audited on [Date]; I will be reviewing the records for all subjects enrolled since the last continuing review approval (Date). I will coordinate the audit with the primary research coordinator on this study, [Name], and will disseminate the findings to the team afterward. Attached to this are three documents for your reference: A copy of the internal audit template that will be used to direct the audit proceedings; a copy of the General Surgery internal auditing SOP; and a copy of the General Surgery Research Compliance Tip Sheet. If you have any questions about protocol compliance, please feel free to contact me at your convenience. CC:[Research Coordinator]

Where and When is it Audited? Audits are Conducted in the Office/Clinic/Lab Where Study Charts are Stored Audits Fall in the Middle of the Continuing Review Cycle (±2 Months) The Auditor Provides Written Notification to the PI and Lead Study Coordinator Approximately Two Weeks in Advance Audits are Scheduled Using Outlook (Appearing on the Research Staff’s Calendar) The PI and Research Staff are Not Present During the Audit The Audit Findings are Disseminated in Writing to the PI, Research Staff, and Regulatory Staff Following the Internal Audit

Answer the questions in Section III (page 2) of your handout to consider the auditing logistics appropriate for your research group.

How is it Audited? Informed Consent Documents and Informed Consent Process Documentation HIPAA Authorizations Subject Eligibility Protocol Compliance (Deviations and Violations) Subject Safety Compliance with the DSMP

How is it Audited? Proper ICS Version and Pagination Proper IRB Approval Stamp(s) on ICS Proper ICS Execution Informed Consent Process Note Review Proper HIPAA Authorization Version and Pagination Proper IRB Approval Stamp on HIPAA Authorization Proper HIPAA Authorization Execution Medical Records Documentation (VA Only)

How is it Audited? Informed Consent Documents and Informed Consent Process Documentation HIPAA Authorizations Subject Eligibility Protocol Compliance (Deviations and Violations) Subject Safety Compliance with the DSMP

How is it Audited? Subject Eligibility – Eligibility Checklist Review and Source Document Verification (Sampling) Protocol Compliance – eCRF Review and Source Document Verification (Sampling)

The Compliance Log

How is it Audited? Subject Eligibility – Eligibility Checklist Review and Source Document Verification (Sampling) Protocol Compliance – eCRF Review and Source Document Verification (Sampling) Subject Safety – Regulatory File Review – eCRF Review and Source Document Verification (Sampling)

The Safety Log

How is it Audited? Subject Eligibility – Eligibility Checklist Review and Source Document Verification (Sampling) Protocol Compliance – eCRF Review and Source Document Verification (Sampling) Subject Safety – eCRF Review and Source Document Verification (Sampling) – Regulatory File Review DSMP Compliance – Regulatory File Review

Answer the questions in Section IV (page 2) of your handout to consider the internal auditing priorities for your research group.

The Coordinator’s Perspective 1.“An ounce of prevention is worth a pound of cure.”

Answer Question 1 in Section V (page 3) of your handout to brainstorm some “preventative actions” for your research practice.

The Coordinator’s Perspective 1.“An ounce of prevention is worth a pound of cure.” 2.Leave a trail of “bread crumbs” for the next person.

Answer Question 2 in Section V (page 3) of your handout to assess how detailed, organized, and reliable you are in your research practice.

The Coordinator’s Perspective 1.“An ounce of prevention is worth a pound of cure.” 2.Leave a trail of “bread crumbs” for the next person. 3.Prep for the “big day”.

The Coordinator’s Perspective 1.“An ounce of prevention is worth a pound of cure.” 2.Leave a trail of “bread crumbs” for the next person. 3.Prep for the “big day”. 4.Turn that frown upside down.

Answer Question 3 in Section V (page 3) of your handout to identify opportunities to promote internal auditing.